Science ❯ Medicine ❯ Clinical Trials
Lenacapavir Inhalation Therapy Oncology FDA Studies
The CHMP’s positive opinion sets the stage for final EU Commission approval to replace high-global-warming-potential propellant with Honeywell’s lower-carbon alternative throughout AstraZeneca’s regional supply
